EP
IRON icon

Essential Partners’s Disc Medicine IRON Stock Holding History

Essential Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366 Buy
5
+1
+25% +$69 ﹤0.01% 2537
2026
Q1 		$256 Hold
4
– – ﹤0.01% 2576
2025
Q4 		$318 Hold
4
– – ﹤0.01% 2326
2025
Q3 		$264 Hold
4
– – ﹤0.01% 2349
2025
Q2 		$212 Buy
+4
New +$188 ﹤0.01% 1929

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Essential Partners's IRON Position: Q2 2026 in Review

Essential Partners increased its Disc Medicine (IRON) stake by 25% in Q2 2026, buying an estimated $69 and bringing the position to 5 shares worth $366. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Essential Partners first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Essential Partners held 5 shares of Disc Medicine worth $366 as of Q2 2026.
  • Essential Partners bought 1 Disc Medicine share in Q2 2026, an estimated $69.
  • Disc Medicine made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2537 holding.
  • Essential Partners first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.